Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Latest From ABOGEN INC

China's 'Two Sessions': Vaccines, Drugs Seen Key To Easing Restrictions Amid New Spike

The latest policies from Beijing show that the Chinese government is readying its own new vaccines and drugs for COVID-19 in a bid to gradually ease some of the strictest pandemic restrictions globally, but progress is mixed and domestic reported infections are surging to their highest level since March 2020.

Coronavirus COVID-19 Policy

China OKs Heterologous Booster Shots Amid Heated COVID Vaccine Race

CanSino and Zhifei have received the regulatory green light for their respective COVID-19 booster shots in China and an estimated $1.3bn vaccine market is now up for grabs. Domestic contenders are set to elbow each other in the sector with a range of viral vector, recombinant protein and mRNA-based jabs.

China Approvals

Hong Kong Issues Vaccine Mandate Amid Local Surge

Hong Kong is having to take drastic new measures, including a vaccine mandate, to fight a rapid surge in COVID-19 cases amid its strict "COVID zero" policies, which might signal potential challenges in the mainland. Meanwhile, US mRNA vaccine developer Moderna has announced an expansion in Asia.

Coronavirus COVID-19 Vaccines

Olympics Foreshadow Beijing's Intention To Follow Own Policy Path?

The Beijing Winter Olympics highlight a changing China that is becoming more confident and confrontational in its policies, although a willingness to challenge international rules could potentially stall the further introductions of novel vaccines and treatments at a critical juncture of the pandemic.

China Policy
See All

Company Information

UsernamePublicRestriction

Register